Home > > > Report Detail

Global Human Growth Hormone Deficiency (GHD) Drugs Market Assessment: Current Market, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023

Publisher Name :
Date: 20-Apr-2018
No. of pages: 130

Executive Summary

The report presents the market potential of four major pipeline drugs (TransCon-hGH, Somapacitan, Somavaratan, Somatrogonmeant) for the treatment of human Growth Hormone Deficiency (GHD). These four drugs that fall in the various categories of paediatrics and adults by end user have been recognized as being clinically effective in human Growth Hormone Deficiency treatment. Expected to be launched in the market within the next 4-5 years, these four potential drugs are likely to bring about major changes in the way Growth Hormone Deficiency is treated globally.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global human Growth Hormone Deficiency (GHD) Pipeline Drugs Market by assessing the potential of the four drugs that will be launched in the near future. Also, the report assesses the results of various clinical trials undertaken for each of the four drugs, the product profile, description and regulatory phase of each of the four drugs. Also, 7Ps Analysis (Patent, Phase, Pathway, Patient, Physician, Payer, Partner) has been done for each of the four drugs to present the current perspective.

The report titled “Global Human Growth Hormones Deficiency (GHD) Drugs Market Assessment: Current Market, Pipeline Review, Clinical Trials, Market Potential – Forecast to 2023” also analyzes the overall sizing, growth and forecast of Growth Hormone Deficiency Drugs Market for the global market.

Over the recent years, the human Growth Hormone Deficiency Drugs market is growing rapidly due to rising prevalence of patients with Growth Hormone Deficiency (GHD) around the world. Globally, the growth of human Growth Hormone Deficiency Drugs market is driven by increased penetration of drugs by market players coupled with introduction of new drugs with improved patient compliance.

The global human Growth Hormone Deficiency (GHD) Pipeline Drugs Market is projected to display a robust growth during 2018 – 2023, chiefly driven by low efficacy and poor dosing schedules of present drugs and improved safety and efficacy of investigational drugs. The report has covered and analysed the present human Growth Hormone Deficiency (GHD) drugs in the market and has also analysed potential of four major pipeline drugs. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation.

Scope of the Report

Global human Growth Hormone Deficiency (GHD) Pipeline Drugs Assessment – TransCon-hGH, Somapacitan, Somavaratan, Somatrogon (Forecast Period: 2020-2023)


  • Market Potential

  • Clinical Trials

  • Product Description

  • Regulatory Phases

  • 7Ps Analysis


Global human Growth Hormone Deficiency (GHD) Pipeline Drugs Market – Sizing and Growth


  • Actual Period: 2013-2017

  • Forecast Period: 2018-2023


Regional Analysis - Human Growth Hormone Deficiency (GHD) Pipeline Drugs Market – Sizing and Growth: North America, Europe, Rest of the World


  • Actual Period: 2013-2017

  • Forecast Period: 2018-2023


Country Analysis - Human Growth Hormone Deficiency (GHD) Pipeline Drugs Market – Sizing and Growth: US, UK, France, Spain, Germany, Japan


  • Actual Period: 2013-2017

  • Forecast Period: 2018-2023


Other Report Highlights


  • Company Analysis – Ascendis Pharma A/S, Novo Nordisk A/S, Versartis Inc., Opko Health Inc., Pfizer Inc.


Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Global Human Growth Hormone Deficiency (GHD) Drugs Market Assessment: Current Market, Pipeline Review, Clinical Trials, Market Potential - Forecast to 2023

Table of Contents

1. Research Methodology

2. Executive Summary

3. Growth Hormone Deficiency Drugs Product - An Overview
3.1. Growth Hormone (GH) and its Function
3.2. Growth Hormone Deficiency (GHD) and its Symptoms
3.3. Causes of Growth Hormone Deficiency (GHD)

4. Diagnosis of Growth Hormone Deficiency (GHD)

5. Treatment of Growth Hormone Deficiency (GHD)

6. Global Growth Hormone Drugs Market
6.1. Global Growth Hormone Drugs Market Size, By value, 2013-2017
6.2. Global Growth Hormone Drugs Market Size, By value, 2018-2023

7. Global Growth Hormone Deficiency Drugs Market
7.1. Global Growth Hormone Deficiency Drugs Market Size, By value, 2013-2017
7.2. Global Growth Hormone Deficiency Drugs Market Size, By value, 2018-2023

8. Global Growth Hormone Deficiency Drugs Market, By End User
8.1. Global Growth Hormone Deficiency Drugs Market, By End User: Break down (%)
8.1.1. Global Growth Hormone Deficiency Drugs Market, By End User: 2017%
8.1.2. Global Growth Hormone Deficiency Drugs Market, By End User: 2023%
8.2. Global Growth Hormone Deficiency Drugs Market, By End User – By Pediatrics
8.2.1. By Value (2013 – 2017)
8.2.2. By Value (2018 – 2023)
8.3. Global Growth Hormone Deficiency Drugs Market, By End User – By Adult
8.3.1. By Value (2013 – 2017)
8.3.2. By Value (2018 – 2023)

9. Global Growth Hormone Deficiency Drugs Market: Regional Analysis
9.1. North America Growth Hormone Deficiency Drugs Market
9.1.1. By Value (2013 – 2017)
9.1.2. By Value (2018 – 2023)
9.2. Europe Growth Hormone Deficiency Drugs Market
9.2.1. By Value (2013 – 2017)
9.2.2. By Value (2018 – 2023)
9.3. ROW Growth Hormone Deficiency Drugs Market
9.3.1. By Value (2013 – 2017)
9.3.2. By Value (2018 – 2023)

10. Global Growth Hormone Deficiency Drugs Market: Country Analysis
10.1. U.S. Growth Hormone Deficiency Drugs Market
10.1.1. By Value (2013 – 2017)
10.1.2. By Value (2018 – 2023)
10.2. U.K. Growth Hormone Deficiency Drugs Market
10.2.1. By Value (2013 – 2017)
10.2.2. By Value (2018 – 2023)
10.3. France Growth Hormone Deficiency Drugs Market
10.3.1. By Value (2013 – 2017)
10.3.2. By Value (2018 – 2023)
10.4. Germany Growth Hormone Deficiency Drugs Market
10.4.1. By Value (2013 – 2017)
10.4.2. By Value (2018 – 2023)
10.5. Spain Growth Hormone Deficiency Drugs Market
10.5.1. By Value (2013 – 2017)
10.5.2. By Value (2018 – 2023)
10.6. Japan Growth Hormone Deficiency Drugs Market
10.6.1. By Value (2013 – 2017)
10.6.2. By Value (2018 – 2023)

11. human Growth Hormone Deficiency (hGHD) Pipeline Drugs - An Analysis
11.1. hGHD Pipeline Drugs – TransCon-hGH
11.1.1. Description
11.1.2. Regulatory Milestones
11.1.3. Advantages & Disadvantages
11.1.4. Product Profile & Launch Date
11.1.5. Clinical Trials and Status
11.1.6. Pivotal Clinical Trials and Results
11.1.7. TransCon-hGH – Global Market Potential
11.1.8. TransCon-hGH – Global Market Potential
11.2. hGHD Pipeline Drugs – Somapacitan
11.2.1. Description
11.2.2. Regulatory Milestones
11.2.3. Advantages & Disadvantages
11.2.4. Product Profile & Launch Date
11.2.5. Clinical Trials and Status
11.2.6. Pivotal Clinical Trials and Results
11.2.7. Somapacitan – Global Market Potential
11.2.8. Somapacitan – 7Ps Analysis
11.3. hGHD Pipeline Drugs – Somavaratan
11.3.1. Description
11.3.2. Regulatory Milestones
11.3.3. Advantages & Disadvantages
11.3.4. Product Profile & Launch Date
11.3.5. Clinical Trials and Status
11.3.6. Pivotal Clinical Trials and Results
11.3.7. Somavaratan – Global Market Potential
11.3.8. Somavaratan – 7Ps Analysis
11.4. hGHD Pipeline Drugs – Somatrogon/ Lagova
11.4.1. Description
11.4.2. Regulatory Milestones
11.4.3. Advantages & Disadvantages
11.4.4. Product Profile & Launch Date
11.4.5. Clinical Trials and Status
11.4.6. Pivotal Clinical Trials and Results
11.4.7. Somatrogon/ Lagova – Global Market Potential
11.4.8. Somatrogon/ Lagova – 7Ps Analysis
11.5. Competitive Landscape

12. Company Profiles
12.1. Ascendis Pharma A/S
12.2. Novo Nordisk A/S
12.3. Versartis Inc.
12.4. Opko Health, Inc.
12.5. Pfizer Inc

List of Tables

Table A: Upcoming Drugs in the market of Growth Hormone Deficiency and their Clinical Status from 2016 - 2020

List of Figures

Figure 1: Global Growth Hormones Drugs Market Size, By value, 2013-2017 (USD Billion)
Figure 2: Global Growth Hormones Drugs Market Size, By value, 2018-2023 (USD Billion)
Figure 3: Global Growth Hormones Market Share 2017
Figure 4: Sales of Growth Hormones, By Value, 2014-2017  
Figure 5: Global Growth Hormone Market Share, 2017 (%)
Figure 6: Global Growth Hormones Deficiency Drugs Market Size, By value, 2013-2017 (USD Billion)
Figure 7: Global Growth Hormones Deficiency Drugs Market Size, By value, 2018-2023 (USD Billion)
Figure 8: Global Growth Hormone Market 2017
Figure 9: Global Growth Hormone Market 2028
Figure 10: Global Growth Hormone Deficiency Drugs Market Share, By End User, 2017 (%)
Figure 11: Global Growth Hormone Deficiency Drugs Market Share, By End User, 2023 (%)
Figure 12: Global Growth Hormone Deficiency Drugs Market, By Pediatrics, By Value, 2013-2017 (USD Billion)
Figure 13: Global Growth Hormone Deficiency Drugs Market, By Pediatrics, By Value, 2018-2023 (USD Billion)
Figure 14: Global Growth Hormone Deficiency Drugs Market, By Adults, By Value, 2013-2017 (USD Billion)
Figure 15: Global Growth Hormone Deficiency Drugs Market, By Adults, By Value, 2018-2023 (USD Billion)
Figure 16: North America Growth Hormone Deficiency Drugs Market Size, By value, 2013-2023 (USD Billion)
Figure 17: Europe Growth Hormone Deficiency Drugs Market Size, By value, 2013-2023 (USD Billion)
Figure 18: ROW Growth Hormone Deficiency Drugs Market Size, By value, 2013-2023 (USD Billion)
Figure 19: US Growth Hormone Deficiency Drugs Market Size, By value, 2013-2023 (USD Billion)
Figure 20: U.S. Per Capita Health Expenditure, 2012-2016 (USD)
Figure 21: U.S Prevalence of Cancer, in cases per 100,000 (2014-2016)
Figure 22: UK Growth Hormone Deficiency Drugs Market Size, By value, 2013-2023 (USD Billion)
Figure 23: France Growth Hormone Deficiency Drugs Market Size, By value, 2013-2023 (USD Billion)
Figure 24: France Per Capita Healthcare Expenditure (USD)
Figure 25: France Prevalence of Cancer, in cases per 100,000 (2014-2016)
Figure 26: Germany Growth Hormone Deficiency Drugs Market Size, By value, 2013-2023 (USD Billion)
Figure 27: Germany Healthcare Expenditure (USD Billion, 2014-2017
Figure 28: Germany Prevalence of Cancer, in cases per 100,000 (2014-2016)
Figure 29: Spain Growth Hormone Deficiency Drugs Market Size, By value, 2013-2023 (USD Billion)
Figure 30: Japan Growth Hormone Deficiency Drugs Market Size, By value, 2013-2023 (USD Billion)
Figure 31: Annualized Height Velocity (Mean + SD) of full dataset of 53 patients after 6 months of treatment
Figure 32: Change in HT SDS (Mean + SD) of full dataset of 53 patients after 6 months of treatment
Figure 33: Dose Proportional IGF-1 Elevation Observed into the Normal Range
Figure 34: Comparable hGH levels for TransCon Growth Hormone and Daily hGH  
Figure 35: Global TransCon hGH Market Size, By Value, Forecast, 2020-2023 (USD million)
Figure 36: Annualized Height Velocity (Mean + SD) of full dataset of 53 patients after 6 months of treatment
Figure 37: Global Somapacitan (NN8640) Market Size, By Value, Forecast, 2020-2023 (USD million)
Figure 38: Height Velocity at 12 months in ITT and PP groups
Figure 39: Global Somavaratan (VRS-317) Market Size, By Value, Forecast, 2020-2023 (USD million)
Figure 40: Mean annualized HV for subjects completed 24 month of once weekly Somatrogon treatment
Figure 41: Mean annualized HV for subjects completed 24 month of once weekly Somatrogon treatment
Figure 42: Global Somatrogon (Lagova) Market Size, By Value, Forecast, 2020-2023 (USD million)
Figure 43: Ascendis Pharma Company Net Sales, By Value, in million €
Figure 44: Novo Nordisk Company Net Sales, By Value, in million DKK
Figure 45: Norditropin® net sales, by value, in million DKK
Figure 46: Pfizer Company Revenue, By Value, in million USD
Figure 47: Genotropin net sales, by value, in million USD

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs